40 likes | 206 Views
International Society for Disease Surveillance Survey of Syndromic Surveillance Uses Marc Paladini, MPH & Amy Sonricker, MPH, ISDS James Buehler, MD, Emory Univ. Farzad Mostashari, MD, MPH, ISDS & NYC DoH&MH. Funded by CDC BioSense program via CDC NACCHO cooperative agreement
E N D
International Society for Disease Surveillance Survey of Syndromic Surveillance UsesMarc Paladini, MPH & Amy Sonricker, MPH, ISDSJames Buehler, MD, Emory Univ. Farzad Mostashari, MD, MPH, ISDS & NYC DoH&MH • Funded by CDC BioSense program via CDC NACCHO cooperative agreement • Phase 1: State survey, inc. territorial & directly-funded local HDs • Phase 2: Local HD survey • Phase 3: Develop registry to support “community of users” • Project advisory group includes • CSTE • NACCHO • ASTHO • CDC
ISDS State Syndromic Surveillance Use Survey41 Respondents- 33 Use Syndromic Surveillance
“Does your health department use BioSense?” • 43 responses (40 states, 3 directly funded local HDs) • Yes: 53% • No: 47% • “If yes, briefly describe your use of BioSense” • Open-ended answers typically described frequency of use (N=22) • 5 review daily • 4 review < daily but > weekly • 6 review, frequency not described • 7 “occasional” or “periodic” review